The Global 1,1-Carbonyldiimidazole Market was valued at USD 47.3 Million in 2025 and is projected to reach USD 57.8 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period (2025–2032). This steady growth is being driven by increasing demand from the pharmaceutical sector, expanding research activities in proteomics and bioconjugation techniques, and the accelerating adoption of high-purity CDI solutions across active pharmaceutical ingredient (API) manufacturing and specialty chemical synthesis.

As the pharmaceutical and fine chemicals industry transforms toward more efficient, selective, and sustainable synthesis pathways, the spotlight is on the key producers who are driving innovation, process optimization, and supply chain reliability. In this blog, we profile the Top 10 Companies in the Global 1,1-Carbonyldiimidazole Industry—a mix of multinational chemical manufacturers, specialty reagent producers, and regional API suppliers shaping the future of this critical chemical market.

---

📺 1. Lanxess AG

Headquarters: Cologne, Germany
Key Offering: High-Purity 1,1-Carbonyldiimidazole (CDI), Specialty Coupling Reagents

Lanxess AG is widely recognized as one of the leading global producers of 1,1-Carbonyldiimidazole, holding an estimated 18–22% share of the global market as of 2024. As a major European specialty chemicals company, Lanxess leverages its well-established distribution networks across Europe and North America to serve pharmaceutical manufacturers, research institutions, and fine chemical producers. The company’s CDI products are used extensively in peptide synthesis, API manufacturing, and advanced coupling reactions requiring high selectivity and minimal byproduct formation.

Key Strengths:

• Broad distribution network across Europe and North America

• Established expertise in specialty and performance chemicals

• Strong regulatory compliance and pharmaceutical-grade product certifications

Download FREE Sample Report:
Global 1,1-Carbonyldiimidazole Market – View in Detailed Research Report

---

&#9️⃣ 2. Atul Limited

Headquarters: Valsad, Gujarat, India
Key Offering: 1,1-Carbonyldiimidazole, Pharmaceutical Intermediates, Fine Chemicals

Atul Limited is one of India’s most diversified chemical companies, with a growing presence in the global CDI market. The company benefits from cost-competitive manufacturing capabilities and has positioned itself as a reliable supplier to both domestic and international pharmaceutical companies. Atul’s integrated chemical operations allow it to maintain quality consistency across product batches, which is particularly critical for pharmaceutical-grade CDI applications.

Key Strengths:

• Cost-competitive production backed by integrated chemical operations

• Strong domestic market presence with growing export capabilities

• Strategic partnerships with API manufacturers across India and Southeast Asia

---

₿ 3. Zhejiang Bulk Chemical Co., Ltd.

Headquarters: Zhejiang Province, China
Key Offering: CDI (98% and 99% Purity Grades), Organic Synthesis Reagents

Zhejiang Bulk Chemical is a prominent Chinese manufacturer of 1,1-Carbonyldiimidazole and has gained significant traction in the Asia-Pacific market. The company supplies both standard and pharmaceutical-grade CDI to customers across China, Japan, South Korea, and international export markets. Its ability to produce at scale while maintaining competitive pricing makes it a preferred sourcing partner for many mid-sized pharmaceutical and chemical companies.

Key Strengths:

• High-volume production capacity serving domestic and export markets

• Competitive pricing due to optimized manufacturing processes

• Growing portfolio of pharmaceutical-grade reagents alongside CDI

---

�� 4. Changzhou Welton Chemical Co., Ltd.

Headquarters: Changzhou, Jiangsu, China
Key Offering: High-Purity CDI, Fine Chemical Reagents, Pharmaceutical Intermediates

Changzhou Welton Chemical has established itself as a key supplier of high-purity CDI in the Asia-Pacific region. The company announced new manufacturing facility expansions since 2022, dedicated specifically to high-purity CDI production aimed at the pharmaceutical and biotechnology sectors. Welton Chemical focuses on delivering pharmaceutical-grade product quality and has been actively pursuing international certifications to broaden its customer base beyond China.

Key Strengths:

• New dedicated manufacturing capacity for high-purity CDI production

• Active pursuit of pharmaceutical-grade certifications for global market access

• Strong technical support and customer service capabilities

Download FREE Sample Report:
Global 1,1-Carbonyldiimidazole Market – View in Detailed Research Report

---

�� 5. Hangzhou FST Pharmaceutical Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Pharmaceutical-Grade CDI, API Intermediates, Research-Grade Reagents

Hangzhou FST Pharmaceutical is a specialized producer focused on pharmaceutical intermediates and research-grade reagents, with CDI being among its flagship product offerings. The company serves pharmaceutical research organizations, contract manufacturing organizations (CMOs), and university research laboratories across Asia and internationally. FST Pharmaceutical’s focus on the pharmaceutical segment gives it a clear advantage in meeting stringent purity requirements demanded by drug development applications.

Key Strengths:

• Pharmaceutical-focused product portfolio with rigorous quality standards

• Dedicated supply to CMOs and pharmaceutical R&D organizations

• Capacity expansion announced for high-purity CDI production lines

---

�� 6. Hangzhou Yunuo Chemical Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: CDI, Carbonylating Agents, Specialty Organic Chemicals

Hangzhou Yunuo Chemical is a well-established supplier of CDI and related carbonylating agents in the Chinese and broader Asian chemical markets. The company serves both industrial chemical manufacturers and pharmaceutical companies, offering CDI in multiple purity grades to address varied application requirements. Yunuo Chemical benefits from Hangzhou’s established chemical industry infrastructure, allowing it to maintain efficient supply chain operations.

Key Strengths:

• Multi-grade CDI supply addressing both industrial and pharmaceutical applications

• Well-positioned within Hangzhou’s established chemical production ecosystem

• Reliable supply chain performance with consistent product availability

---

�� 7. Quzhou Ruilijie Chemical Industry Co., Ltd.

Headquarters: Quzhou, Zhejiang, China
Key Offering: CDI, Specialty Chemical Intermediates, Organic Synthesis Reagents

Quzhou Ruilijie Chemical Industry is strengthening its market position through backward integration strategies, securing raw material supplies to reduce vulnerability to feedstock price volatility. The company is also actively pursuing pharmaceutical-grade certifications to access premium market segments within the CDI value chain. Ruilijie’s focus on supply chain resilience and product quality improvement positions it as a growing force among Chinese CDI producers.

Key Strengths:

• Backward integration strategy to stabilize raw material costs and supply

• Active pharmaceutical-grade certification pursuit for higher-value market access

• Competitive cost structure supporting price-sensitive industrial applications

---

�� 8. Changzhou Zhongkai Chemical Co., Ltd.

Headquarters: Changzhou, Jiangsu, China
Key Offering: CDI, Fine Chemical Reagents, Organic Coupling Agents

Changzhou Zhongkai Chemical is a reliable regional producer of CDI and fine chemical reagents, primarily serving the domestic Chinese pharmaceutical and agrochemical industries. The company has built a reputation for consistent product quality and responsive customer service, which has helped it maintain stable relationships with mid-tier pharmaceutical manufacturers. Zhongkai Chemical’s operations are supported by Changzhou’s well-developed chemical industry base, providing ready access to skilled labor and technical expertise.

Key Strengths:

• Consistent product quality serving domestic pharmaceutical and agrochemical sectors

• Stable client relationships with mid-tier API manufacturers

• Favorable location within Changzhou’s established chemical industry hub

---

�� 9. Shanghai Holdenchem Co., Ltd.

Headquarters: Shanghai, China
Key Offering: CDI, Laboratory Chemicals, Research-Grade Reagents

Shanghai Holdenchem operates as a specialized distributor and producer of laboratory chemicals, with CDI among its key product offerings for the research and pharmaceutical development market. The company’s Shanghai base provides a strategic advantage in terms of logistics and access to international trade networks, enabling efficient export to customers across Asia, Europe, and North America. Holdenchem focuses on research-grade and high-purity CDI applications, catering to the growing bioconjugation and proteomics research communities.

Key Strengths:

• Strategic Shanghai location enabling efficient international trade and logistics

• Focus on research-grade CDI for bioconjugation and proteomics applications

• Broad catalog of complementary laboratory chemicals supporting bundled supply

Download FREE Sample Report:
Global 1,1-Carbonyldiimidazole Market – View in Detailed Research Report

---

1️⃣ 10. Jiangxi Jinkai Chemical Co., Ltd.

Headquarters: Jiangxi Province, China
Key Offering: CDI, Organic Intermediates, Specialty Chemicals

Jiangxi Jinkai Chemical is an emerging player in the CDI market, leveraging backward integration to secure raw material supplies and improve production cost efficiency. The company is advancing its position in the market by focusing on quality improvements and supply reliability, which are critical factors for pharmaceutical customers requiring consistent reagent performance. Jinkai Chemical’s competitive pricing and growing production capabilities make it a notable participant in the evolving CDI supply landscape.

Key Strengths:

• Backward integration supporting raw material cost control and supply stability

• Growing production capabilities with focus on pharmaceutical-grade quality improvements

• Competitive pricing positioning in price-sensitive industrial and agrochemical segments

Get Full Report Here:
Global 1,1-Carbonyldiimidazole Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the 1,1-Carbonyldiimidazole Market Is Innovation-Driven and Pharma-Led

The global 1,1-Carbonyldiimidazole market is undergoing a meaningful transformation. While the compound has long served as a workhorse reagent in pharmaceutical synthesis, the industry is now investing in higher-purity production systems, greener manufacturing approaches, and expanded application development to unlock new growth pathways. The convergence of biologics development, peptide therapeutics, and bioconjugation technologies is creating sustained demand well beyond conventional small-molecule synthesis.

📈 Key Trends Shaping the Market:

• Rapid expansion of peptide-based therapeutics driving high-purity CDI consumption in pharmaceutical manufacturing

• Growing adoption of CDI in antibody-drug conjugate (ADC) development and bioconjugation platforms

• Shift toward greener synthesis routes positioning CDI as a preferred lower-toxicity coupling reagent

• Capacity expansions by Asian manufacturers reshaping global supply dynamics and regional pricing

• Emerging market pharmaceutical investments in India and Southeast Asia opening new demand frontiers

Get Full Report Here:
Global 1,1-Carbonyldiimidazole Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical chemical reagent—they’re enabling the next generation of pharmaceutical breakthroughs and specialty chemical innovations that are reshaping industries worldwide.